Overactive Bladder: Where We Are and Where We Are Going
Overactive bladder (OAB) is a heterogeneous syndrome estimated to affect approximately 10% to 15% of men and women globally. OAB not only negatively impacts quality of life but also results in a significant financial burden to both patients and health systems. Therefore, it is crucial that OAB is pr...
Main Authors: | Charan S. Mohan, Wai Lee, Kathleen C. Kobashi |
---|---|
Format: | Article |
Language: | English |
Published: |
The Société Internationale d’Urologie (SIU)
2021-09-01
|
Series: | Société Internationale d’Urologie Journal |
Subjects: |
Similar Items
-
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01) -
An examination of Overactive Bladder Syndrome: present comprehension, methods of treatment, and innovative approaches
by: Zuzanna Kotowicz, et al.
Published: (2024-03-01) -
Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01) -
Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01) -
A positive association between food insecurity and the prevalence of overactive bladder in U.S. adults
by: Yunfei Xiao, et al.
Published: (2024-01-01)